Appendix B
Anatomical Therapeutic Chemical (ATC) codes used to identify cardiovascular-related medications
| Medication | ATC code | ATC description | Excluding |
|---|---|---|---|
| Anti-hypertensives | C02 C03 C07 C08 C09 |
Miscellaneous anti-hypertensives Thiazide diurectics Beta-blockers Calcium channel antagonists Agents acting on the Renin-Angiotensin system |
C02KX01 C03BA08, C03CA01 C07AA07, C07AA12, C07AG02 |
| Lipid modifiers (statins) | C10AA C10AB C10AC C10AD C10AX C10BA C10BX |
HMG COA reductase inhibitors Fibrates Bile acid sequestrants Nicotinic acid and derivatives Other lipid modifying agents HMG CoA reductase inhibitors in combination with other lipid-modifying agents HMG CoA reductase inhibitors, other combinations |
|
| Anti-thrombotic agents (anti-coagulants) | B01AA B01AB B01AE B01AF |
Vitamin K antagonists Heparin group Direct thrombin inhibitors Direct factor Xa inhibitors |
|
| Anti-platelets | B01AC | Platelet aggregation inhibitors excluding heparin | |
|
Note: Selection of medications uses codes based on: Wilkins K, Gee M, Campbell N. The difference in hypertension control between older women and men. Health Reports 2012, 23(4). Available at: http://www.statcan.gc.ca/pub/82-003-x/2012004/article/11721-eng.pdf Source: World Health Organization. |
|||
- Date modified: